The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma |
Emory University / Shubin Shahab, MD/PhD |
Young Investigator Grants |
2021 |
Georgia |
Stapled Peptide PROTAC: A 3-in-1 Treatment for Pediatric Solid Tumors |
Dana-Farber Cancer Institute / Loren Walensky, MD/PhD |
Reach Grants |
2021 |
Massachusetts |
Optimization of Drug Efflux and Brain Clearance to Improve CED of Targeted Therapy to H3K27M DMG |
Mayo Clinic / David Daniels, MD/PhD |
Reach Grants |
2021 |
Minnesota |
IND-Enabling Studies for WNTinib, a Novel Selective Therapeutic for CTNNB1 Mutant Hepatoblastomas |
Icahn School of Medicine at Mount Sinai / Ernesto Guccione, PhD & Josep Llovet, MD & Arvin Dar, PhD |
Reach Grants |
2021 |
New York |
The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes |
Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD |
'A' Award Grants |
2021 |
Massachusetts |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma |
Board of Trustees of the Leland Stanford Junior University / Michelle Monje |
Catalyst Grants |
2021 |
California |
Circulating Tumor Biomarkers: New Paradigms for Management of Neuroblastoma |
University of Chicago / Mark Applebaum, PhD |
'A' Award Grants |
2021 |
Illinois |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders |
Boston Children's Hospital / Serine Avagyan, MD/PhD |
RUNX1 Early Career Investigator Grants |
2021 |
Massachusetts |
Targeting the Rac GTPase Pathway to Sabotage RAS Signaling in RAS-mutated Leukemia |
Boston Children's Hospital / Sara Canovas Nunes, PhD |
Young Investigator Grants |
2020 |
Massachusetts |